HM12470 clinical trials
Also written HM12470.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2015
How each study uses HM12470 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- HM12470
- 3
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses HM12470 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470CompletedPhase 1Hanmi Pharmaceutical Company LimitedNCT02302443Written as HM12470
- Molar Potency Study of HM12470 in Healthy SubjectsCompletedPhase 1Hanmi Pharmaceutical Company LimitedNCT03330327Written as HM12470
- Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes MellitusStatus unknownPhase 1Hanmi Pharmaceutical Company LimitedNCT03332849Written as HM12470